⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BVS News
Bioventus Inc. Class A Common Stock
Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
globenewswire.com
BVS
Did Bioventus Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
BVS
Bluevine Surpasses 1 Million Small Businesses Served, $2 Billion on Deposit, $17 Billion in Originations
prnewswire.com
BVS
Form 8-K
sec.gov
NATL
BVS
EEFT
Black & Veatch welcomes First Minister of Scotland to Boston to discuss advancing investment in Scotland’s energy sector
businesswire.com
BVS
Perseus Information Security Consulting Becomes Fully Accredited Certification Body for ISASecure ACSSA Program
prnewswire.com
HON
JCI
SWKS
AMZN
SNPS
CDNS
NVDA
AMD
INTC
MSFT
GOOGL
IBM
CSCO
PANW
CRWD
FTNT
DDOG
PLTR
SNOW
ADBE
ORCL
SAP
CRM
NOW
MRVL
QCOM
MU
AMAT
LRCX
KLAC
ASML
TXN
ADI
NXPI
ON
INFY
CTSH
ACN
HPQ
DELL
MSI
AVGO
MCHP
STM
RELI
XOM
CVX
SHEL
GSK
YPF
BVS
CAR
SE
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
prnewswire.com
IART
ORGO
MDXG
BVS
CNXU
Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference
globenewswire.com
BVS
SHAREHOLDER ALERT: Levi & Korsinsky Issues Amended Summary Notice of Class Action Settlement
prnewswire.com
BVS
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
prnewswire.com
IART
MESO
EOLS
BVS
CNXU